Steris (STE) Income from Non-Controlling Interests (2018 - 2026)
Steris (STE) posted Income from Non-Controlling Interests of $900000.0 for Q2 2026, up 800.0% on a QoQ basis from $100000.0 in Q1 2026, and up 50.0% year-over-year from $600000.0 in Q2 2025.
Powered by 
Analysis
Steris (STE) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
Steris has reported Income from Non-Controlling Interests for 9 years, with the latest figure at $900000.0 in Q2 2026.
- On a quarterly basis, Income from Non-Controlling Interests rose 50.0% year-over-year to $900000.0 in Q2 2026; TTM through Jun 2026 was $3.1 million, a 63.16% increase from a year earlier, with the FY2026 full-year figure at $2.8 million, up 100.0% from the prior year.
- Income from Non-Controlling Interests was $900000.0 for Q2 2026 at Steris, up from $100000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $1.5 million in Q4 2025, with the low at -$507000.0 in Q2 2022.
- Average Income from Non-Controlling Interests over 5 years is $304166.7, with a median of $219000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Income from Non-Controlling Interests sank 433.68% in 2022, then jumped 1801.85% in 2023.
- Over 5 years, Income from Non-Controlling Interests stood at -$503000.0 in 2022, then surged by 140.16% to $202000.0 in 2023, then slumped by 199.01% to -$200000.0 in 2024, then soared by 850.0% to $1.5 million in 2025, then sank by 40.0% to $900000.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at $900000.0 (Q2 2026), $100000.0 (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 900,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 1.50 Mn |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 335,000.00 |
| Dec 31, 2023 | 202,000.00 |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 236,000.00 |
| Mar 31, 2023 | -261,000.00 |
| Dec 31, 2022 | -503,000.00 |
| Sep 30, 2022 | 54,000.00 |
| Jun 30, 2022 | -507,000.00 |
| Mar 31, 2022 | -208,000.00 |
| Dec 31, 2021 | -529,000.00 |
| Sep 30, 2021 | -186,000.00 |